866-997-4948(US-Canada Toll Free)

EMEA (Europe, Middle East and Africa) Disease Control and Prevention Vaccine Market Report 2018

Published By :

QYResearch

Published Date : Jul 2018

Category :

Pharmaceutical

No. of Pages : 107 Pages

In this report, the EMEA Disease Control and Prevention Vaccine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Disease Control and Prevention Vaccine for these regions, from 2013 to 2025 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Disease Control and Prevention Vaccine market competition by top manufacturers/players, with Disease Control and Prevention Vaccine sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
GSK
Merck & Co., Inc
Pfizer
Sanofi
AstraZeneca PLC
Sinovac Biotech Ltd
Astellas Pharma Inc
Serum Institute of India Pvt. Ltd
Daiichi Sankyo

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Live-Attenuated
Inactivated
Recombinant Sub Unit and Toxoid

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Pediatric Vaccine
Adult Vaccine

Table of Contents

EMEA (Europe, Middle East and Africa) Disease Control and Prevention Vaccine Market Report 2018
1 Disease Control and Prevention Vaccine Overview
1.1 Product Overview and Scope of Disease Control and Prevention Vaccine
1.2 Classification of Disease Control and Prevention Vaccine
1.2.1 EMEA Disease Control and Prevention Vaccine Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 EMEA Disease Control and Prevention Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Live-Attenuated
1.2.4 Inactivated
1.2.5 Recombinant Sub Unit and Toxoid
1.3 EMEA Disease Control and Prevention Vaccine Market by Application/End Users
1.3.1 EMEA Disease Control and Prevention Vaccine Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.2 Pediatric Vaccine
1.3.3 Adult Vaccine
1.4 EMEA Disease Control and Prevention Vaccine Market by Region
1.4.1 EMEA Disease Control and Prevention Vaccine Market Size (Value) Comparison by Region (2013-2025)
1.4.2 Europe Status and Prospect (2013-2025)
1.4.3 Middle East Status and Prospect (2013-2025)
1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Disease Control and Prevention Vaccine (2013-2025)
1.5.1 EMEA Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2025)
1.5.2 EMEA Disease Control and Prevention Vaccine Revenue and Growth Rate (2013-2025)

2 EMEA Disease Control and Prevention Vaccine Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Disease Control and Prevention Vaccine Market Competition by Players/Manufacturers
2.1.1 EMEA Disease Control and Prevention Vaccine Sales Volume and Market Share of Major Players (2013-2018)
2.1.2 EMEA Disease Control and Prevention Vaccine Revenue and Share by Players (2013-2018)
2.1.3 EMEA Disease Control and Prevention Vaccine Sale Price by Players (2013-2018)
2.2 EMEA Disease Control and Prevention Vaccine (Volume and Value) by Type/Product Category
2.2.1 EMEA Disease Control and Prevention Vaccine Sales and Market Share by Type (2013-2018)
2.2.2 EMEA Disease Control and Prevention Vaccine Revenue and Market Share by Type (2013-2018)
2.2.3 EMEA Disease Control and Prevention Vaccine Sale Price by Type (2013-2018)
2.3 EMEA Disease Control and Prevention Vaccine (Volume) by Application
2.4 EMEA Disease Control and Prevention Vaccine (Volume and Value) by Region
2.4.1 EMEA Disease Control and Prevention Vaccine Sales and Market Share by Region (2013-2018)
2.4.2 EMEA Disease Control and Prevention Vaccine Revenue and Market Share by Region (2013-2018)
2.4.3 EMEA Disease Control and Prevention Vaccine Sales Price by Region (2013-2018)

3 Europe Disease Control and Prevention Vaccine (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Disease Control and Prevention Vaccine Sales and Value (2013-2018)
3.1.1 Europe Disease Control and Prevention Vaccine Sales Volume and Growth Rate (2013-2018)
3.1.2 Europe Disease Control and Prevention Vaccine Revenue and Growth Rate (2013-2018)
3.2 Europe Disease Control and Prevention Vaccine Sales and Market Share by Type
3.3 Europe Disease Control and Prevention Vaccine Sales and Market Share by Application
3.4 Europe Disease Control and Prevention Vaccine Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Disease Control and Prevention Vaccine Sales Volume by Countries (2013-2018)
3.4.2 Europe Disease Control and Prevention Vaccine Revenue by Countries (2013-2018)
3.4.3 Germany Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
3.4.4 France Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
3.4.5 UK Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
3.4.6 Russia Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
3.4.7 Italy Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
3.4.8 Benelux Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)

4 Middle East Disease Control and Prevention Vaccine (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Disease Control and Prevention Vaccine Sales and Value (2013-2018)
4.1.1 Middle East Disease Control and Prevention Vaccine Sales Volume and Growth Rate (2013-2018)
4.1.2 Middle East Disease Control and Prevention Vaccine Revenue and Growth Rate (2013-2018)
4.2 Middle East Disease Control and Prevention Vaccine Sales and Market Share by Type
4.3 Middle East Disease Control and Prevention Vaccine Sales and Market Share by Application
4.4 Middle East Disease Control and Prevention Vaccine Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Disease Control and Prevention Vaccine Sales Volume by Countries (2013-2018)
4.4.2 Middle East Disease Control and Prevention Vaccine Revenue by Countries (2013-2018)
4.4.3 Saudi Arabia Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
4.4.4 Israel Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
4.4.5 UAE Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
4.4.6 Iran Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)

5 Africa Disease Control and Prevention Vaccine (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Disease Control and Prevention Vaccine Sales and Value (2013-2018)
5.1.1 Africa Disease Control and Prevention Vaccine Sales Volume and Growth Rate (2013-2018)
5.1.2 Africa Disease Control and Prevention Vaccine Revenue and Growth Rate (2013-2018)
5.2 Africa Disease Control and Prevention Vaccine Sales and Market Share by Type
5.3 Africa Disease Control and Prevention Vaccine Sales and Market Share by Application
5.4 Africa Disease Control and Prevention Vaccine Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Disease Control and Prevention Vaccine Sales Volume by Countries (2013-2018)
5.4.2 Africa Disease Control and Prevention Vaccine Revenue by Countries (2013-2018)
5.4.3 South Africa Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
5.4.4 Nigeria Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
5.4.5 Egypt Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)
5.4.6 Algeria Disease Control and Prevention Vaccine Sales and Growth Rate (2013-2018)

6 EMEA Disease Control and Prevention Vaccine Manufacturers/Players Profiles and Sales Data
6.1 GSK
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Disease Control and Prevention Vaccine Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 GSK Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Merck & Co., Inc
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Disease Control and Prevention Vaccine Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Merck & Co., Inc Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Pfizer
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Disease Control and Prevention Vaccine Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Pfizer Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Sanofi
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Disease Control and Prevention Vaccine Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Sanofi Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 AstraZeneca PLC
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Disease Control and Prevention Vaccine Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 AstraZeneca PLC Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Sinovac Biotech Ltd
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Disease Control and Prevention Vaccine Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 Astellas Pharma Inc
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Disease Control and Prevention Vaccine Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Astellas Pharma Inc Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Serum Institute of India Pvt. Ltd
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Disease Control and Prevention Vaccine Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 Daiichi Sankyo
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Disease Control and Prevention Vaccine Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Daiichi Sankyo Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview

7 Disease Control and Prevention Vaccine Manufacturing Cost Analysis
7.1 Disease Control and Prevention Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Disease Control and Prevention Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Disease Control and Prevention Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Disease Control and Prevention Vaccine Major Manufacturers in 2017
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Disease Control and Prevention Vaccine Market Forecast (2018-2025)
11.1 EMEA Disease Control and Prevention Vaccine Sales, Revenue and Price Forecast (2018-2025)
11.1.1 EMEA Disease Control and Prevention Vaccine Sales and Growth Rate Forecast (2018-2025)
11.1.2 EMEA Disease Control and Prevention Vaccine Revenue and Growth Rate Forecast (2018-2025)
11.1.3 EMEA Disease Control and Prevention Vaccine Price and Trend Forecast (2018-2025)
11.2 EMEA Disease Control and Prevention Vaccine Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Disease Control and Prevention Vaccine Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Disease Control and Prevention Vaccine Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Disease Control and Prevention Vaccine Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Disease Control and Prevention Vaccine Sales Forecast by Type (2018-2025)
11.7 EMEA Disease Control and Prevention Vaccine Sales Forecast by Application (2018-2025)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer

List of Table

List of Tables and Figures

Figure Product Picture of Disease Control and Prevention Vaccine
Figure EMEA Disease Control and Prevention Vaccine Sales Volume (K Units) by Type (2013-2025)
Figure EMEA Disease Control and Prevention Vaccine Sales Volume Market Share by Type (Product Category) in 2017
Figure Live-Attenuated Product Picture
Figure Inactivated Product Picture
Figure Recombinant Sub Unit and Toxoid Product Picture
Figure EMEA Disease Control and Prevention Vaccine Sales Volume (K Units) by Application (2013-2025)
Figure EMEA Sales Market Share of Disease Control and Prevention Vaccine by Application in 2017
Figure Pediatric Vaccine Examples
Table Key Downstream Customer in Pediatric Vaccine
Figure Adult Vaccine Examples
Table Key Downstream Customer in Adult Vaccine
Figure EMEA Disease Control and Prevention Vaccine Market Size (Million USD) by Region (2013-2025)
Figure Europe Disease Control and Prevention Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Disease Control and Prevention Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Disease Control and Prevention Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Disease Control and Prevention Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Africa Disease Control and Prevention Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Disease Control and Prevention Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Disease Control and Prevention Vaccine Sales Volume and Growth Rate (2013-2025)
Figure EMEA Disease Control and Prevention Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Disease Control and Prevention Vaccine Market Major Players Product Sales Volume (K Units) (2013-2018)
Table EMEA Disease Control and Prevention Vaccine Sales Volume (K Units) of Major Players (2013-2018)
Table EMEA Disease Control and Prevention Vaccine Sales Share by Players (2013-2018)
Figure 2017 Disease Control and Prevention Vaccine Sales Share by Players
Figure 2017 Disease Control and Prevention Vaccine Sales Share by Players
Figure EMEA Disease Control and Prevention Vaccine Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Disease Control and Prevention Vaccine Revenue (Million USD) by Players (2013-2018)
Table EMEA Disease Control and Prevention Vaccine Revenue Share by Players (2013-2018)
Table 2017 EMEA Disease Control and Prevention Vaccine Revenue Share by Players
Table 2017 EMEA Disease Control and Prevention Vaccine Revenue Share by Players
Table EMEA Disease Control and Prevention Vaccine Sale Price (USD/Unit) by Players (2013-2018)
Table EMEA Disease Control and Prevention Vaccine Sales (K Units) and Market Share by Type (2013-2018)
Table EMEA Disease Control and Prevention Vaccine Sales Share by Type (2013-2018)
Figure Sales Market Share of Disease Control and Prevention Vaccine by Type (2013-2018)
Figure EMEA Disease Control and Prevention Vaccine Sales Market Share by Type (2013-2018)
Table EMEA Disease Control and Prevention Vaccine Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Disease Control and Prevention Vaccine Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Disease Control and Prevention Vaccine by Type in 2017
Table EMEA Disease Control and Prevention Vaccine Sale Price (USD/Unit) by Type (2013-2018)
Table EMEA Disease Control and Prevention Vaccine Sales (K Units) and Market Share by Application (2013-2018)
Table EMEA Disease Control and Prevention Vaccine Sales Share by Application (2013-2018)
Figure Sales Market Share of Disease Control and Prevention Vaccine by Application (2013-2018)
Figure EMEA Disease Control and Prevention Vaccine Sales Market Share by Application in 2017
Table EMEA Disease Control and Prevention Vaccine Sales (K Units) and Market Share by Region (2013-2018)
Table EMEA Disease Control and Prevention Vaccine Sales Share by Region (2013-2018)
Figure Sales Market Share of Disease Control and Prevention Vaccine by Region (2013-2018)
Figure EMEA Disease Control and Prevention Vaccine Sales Market Share in 2017
Table EMEA Disease Control and Prevention Vaccine Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Disease Control and Prevention Vaccine Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Disease Control and Prevention Vaccine by Region (2013-2018)
Figure EMEA Disease Control and Prevention Vaccine Revenue Market Share Regions in 2017
Table EMEA Disease Control and Prevention Vaccine Sales Price (USD/Unit) by Region (2013-2018)
Figure Europe Disease Control and Prevention Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Disease Control and Prevention Vaccine Revenue and Growth Rate (2013-2018)
Table Europe Disease Control and Prevention Vaccine Sales (K Units) by Type (2013-2018)
Table Europe Disease Control and Prevention Vaccine Market Share by Type (2013-2018)
Figure Europe Disease Control and Prevention Vaccine Market Share by Type in 2017
Table Europe Disease Control and Prevention Vaccine Sales (K Units) by Application (2013-2018)
Table Europe Disease Control and Prevention Vaccine Market Share by Application (2013-2018)
Figure Europe Disease Control and Prevention Vaccine Market Share by Application in 2017
Table Europe Disease Control and Prevention Vaccine Sales (K Units) by Countries (2013-2018)
Table Europe Disease Control and Prevention Vaccine Sales Market Share by Countries (2013-2018)
Figure Europe Disease Control and Prevention Vaccine Sales Market Share by Countries (2013-2018)
Figure Europe Disease Control and Prevention Vaccine Sales Market Share by Countries in 2017
Table Europe Disease Control and Prevention Vaccine Revenue (Million USD) by Countries (2013-2018)
Table Europe Disease Control and Prevention Vaccine Revenue Market Share by Countries (2013-2018)
Figure Europe Disease Control and Prevention Vaccine Revenue Market Share by Countries (2013-2018)
Figure Europe Disease Control and Prevention Vaccine Revenue Market Share by Countries in 2017
Figure Germany Disease Control and Prevention Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure France Disease Control and Prevention Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure UK Disease Control and Prevention Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Russia Disease Control and Prevention Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Italy Disease Control and Prevention Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Benelux Disease Control and Prevention Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Disease Control and Prevention Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Disease Control and Prevention Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Disease Control and Prevention Vaccine Sales (K Units) by Type (2013-2018)
Table Middle East Disease Control and Prevention Vaccine Market Share by Type (2013-2018)
Figure Middle East Disease Control and Prevention Vaccine Market Share by Type (2013-2018)
Table Middle East Disease Control and Prevention Vaccine Sales (K Units) by Applications (2013-2018)
Table Middle East Disease Control and Prevention Vaccine Market Share by Applications (2013-2018)
Figure Middle East Disease Control and Prevention Vaccine Sales Market Share by Application in 2017
Table Middle East Disease Control and Prevention Vaccine Sales Volume (K Units) by Countries (2013-2018)
Table Middle East Disease Control and Prevention Vaccine Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Disease Control and Prevention Vaccine Sales Volume Market Share by Countries in 2017
Table Middle East Disease Control and Prevention Vaccine Revenue (Million USD) by Countries (2013-2018)
Table Middle East Disease Control and Prevention Vaccine Revenue Market Share by Countries (2013-2018)
Figure Middle East Disease Control and Prevention Vaccine Revenue Market Share by Countries (2013-2018)
Figure Middle East Disease Control and Prevention Vaccine Revenue Market Share by Countries in 2017
Figure Saudi Arabia Disease Control and Prevention Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Israel Disease Control and Prevention Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure UAE Disease Control and Prevention Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Iran Disease Control and Prevention Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Disease Control and Prevention Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Disease Control and Prevention Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Disease Control and Prevention Vaccine Sales (K Units) by Type (2013-2018)
Table Africa Disease Control and Prevention Vaccine Sales Market Share by Type (2013-2018)
Figure Africa Disease Control and Prevention Vaccine Sales Market Share by Type (2013-2018)
Figure Africa Disease Control and Prevention Vaccine Sales Market Share by Type in 2017
Table Africa Disease Control and Prevention Vaccine Sales (K Units) by Application (2013-2018)
Table Africa Disease Control and Prevention Vaccine Sales Market Share by Application (2013-2018)
Figure Africa Disease Control and Prevention Vaccine Sales Market Share by Application (2013-2018)
Table Africa Disease Control and Prevention Vaccine Sales Volume (K Units) by Countries (2013-2018)
Table Africa Disease Control and Prevention Vaccine Sales Market Share by Countries (2013-2018)
Figure Africa Disease Control and Prevention Vaccine Sales Market Share by Countries (2013-2018)
Figure Africa Disease Control and Prevention Vaccine Sales Market Share by Countries in 2017
Table Africa Disease Control and Prevention Vaccine Revenue (Million USD) by Countries (2013-2018)
Table Africa Disease Control and Prevention Vaccine Revenue Market Share by Countries (2013-2018)
Figure Africa Disease Control and Prevention Vaccine Revenue Market Share by Countries (2013-2018)
Figure Africa Disease Control and Prevention Vaccine Revenue Market Share by Countries in 2017
Figure South Africa Disease Control and Prevention Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Nigeria Disease Control and Prevention Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Egypt Disease Control and Prevention Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Algeria Disease Control and Prevention Vaccine Sales (K Units) and Growth Rate (2013-2018)
Table GSK Disease Control and Prevention Vaccine Basic Information List
Table GSK Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GSK Disease Control and Prevention Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure GSK Disease Control and Prevention Vaccine Sales Market Share in EMEA (2013-2018)
Figure GSK Disease Control and Prevention Vaccine Revenue Market Share in EMEA (2013-2018)
Table Merck & Co., Inc Disease Control and Prevention Vaccine Basic Information List
Table Merck & Co., Inc Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck & Co., Inc Disease Control and Prevention Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Merck & Co., Inc Disease Control and Prevention Vaccine Sales Market Share in EMEA (2013-2018)
Figure Merck & Co., Inc Disease Control and Prevention Vaccine Revenue Market Share in EMEA (2013-2018)
Table Pfizer Disease Control and Prevention Vaccine Basic Information List
Table Pfizer Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Disease Control and Prevention Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Pfizer Disease Control and Prevention Vaccine Sales Market Share in EMEA (2013-2018)
Figure Pfizer Disease Control and Prevention Vaccine Revenue Market Share in EMEA (2013-2018)
Table Sanofi Disease Control and Prevention Vaccine Basic Information List
Table Sanofi Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi Disease Control and Prevention Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Sanofi Disease Control and Prevention Vaccine Sales Market Share in EMEA (2013-2018)
Figure Sanofi Disease Control and Prevention Vaccine Revenue Market Share in EMEA (2013-2018)
Table AstraZeneca PLC Disease Control and Prevention Vaccine Basic Information List
Table AstraZeneca PLC Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AstraZeneca PLC Disease Control and Prevention Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure AstraZeneca PLC Disease Control and Prevention Vaccine Sales Market Share in EMEA (2013-2018)
Figure AstraZeneca PLC Disease Control and Prevention Vaccine Revenue Market Share in EMEA (2013-2018)
Table Sinovac Biotech Ltd Disease Control and Prevention Vaccine Basic Information List
Table Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales Market Share in EMEA (2013-2018)
Figure Sinovac Biotech Ltd Disease Control and Prevention Vaccine Revenue Market Share in EMEA (2013-2018)
Table Astellas Pharma Inc Disease Control and Prevention Vaccine Basic Information List
Table Astellas Pharma Inc Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Astellas Pharma Inc Disease Control and Prevention Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Astellas Pharma Inc Disease Control and Prevention Vaccine Sales Market Share in EMEA (2013-2018)
Figure Astellas Pharma Inc Disease Control and Prevention Vaccine Revenue Market Share in EMEA (2013-2018)
Table Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Basic Information List
Table Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales Market Share in EMEA (2013-2018)
Figure Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Revenue Market Share in EMEA (2013-2018)
Table Daiichi Sankyo Disease Control and Prevention Vaccine Basic Information List
Table Daiichi Sankyo Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Daiichi Sankyo Disease Control and Prevention Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Daiichi Sankyo Disease Control and Prevention Vaccine Sales Market Share in EMEA (2013-2018)
Figure Daiichi Sankyo Disease Control and Prevention Vaccine Revenue Market Share in EMEA (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Disease Control and Prevention Vaccine
Figure Manufacturing Process Analysis of Disease Control and Prevention Vaccine
Figure Disease Control and Prevention Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Disease Control and Prevention Vaccine Major Manufacturers in 2017
Table Major Buyers of Disease Control and Prevention Vaccine
Table Distributors/Traders List
Figure EMEA Disease Control and Prevention Vaccine Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure EMEA Disease Control and Prevention Vaccine Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Disease Control and Prevention Vaccine Price (USD/Unit) and Trend Forecast (2018-2025)
Table EMEA Disease Control and Prevention Vaccine Sales (K Units) Forecast by Region (2018-2025)
Figure EMEA Disease Control and Prevention Vaccine Sales Market Share Forecast by Region (2018-2025)
Table EMEA Disease Control and Prevention Vaccine Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Disease Control and Prevention Vaccine Revenue Market Share Forecast by Region (2018-2025)
Table Europe Disease Control and Prevention Vaccine Sales (K Units) Forecast by Countries (2018-2025)
Figure Europe Disease Control and Prevention Vaccine Sales Market Share Forecast by Countries (2018-2025)
Table Europe Disease Control and Prevention Vaccine Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Disease Control and Prevention Vaccine Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Disease Control and Prevention Vaccine Sales (K Units) Forecast by Countries (2018-2025)
Figure Middle East Disease Control and Prevention Vaccine Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Disease Control and Prevention Vaccine Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Disease Control and Prevention Vaccine Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Disease Control and Prevention Vaccine Sales (K Units) Forecast by Countries (2018-2025)
Figure Africa Disease Control and Prevention Vaccine Sales Market Share Forecast by Countries (2018-2025)
Table Africa Disease Control and Prevention Vaccine Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Disease Control and Prevention Vaccine Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Disease Control and Prevention Vaccine Sales (K Units) Forecast by Type (2018-2025)
Figure EMEA Disease Control and Prevention Vaccine Sales Market Share Forecast by Type (2018-2025)
Table EMEA Disease Control and Prevention Vaccine Sales (K Units) Forecast by Application (2018-2025)
Figure EMEA Disease Control and Prevention Vaccine Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *